<DOC>
	<DOCNO>NCT02066792</DOCNO>
	<brief_summary>The purpose study examine efficacy 50 mg d-cycloserine comparison placebo ( pill contain medication ) improve effectiveness cognitive-behavioral therapy ( CBT ) reduce symptom associate social anxiety disorder . In addition , study examine whether effectiveness d-cycloserine depends time pill administration ( i.e. , 1- hour session immediately session ) well success CBT therapy session . The investigator hypothesize tailor post-session DCS administration condition outperform condition ( pre-session DCS , placebo , non-tailored post-session DCS ) . This evidence short- long-term improvement social anxiety severity .</brief_summary>
	<brief_title>Dose Timing D-Cycloserine Augment CBT Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Male female outpatient &gt; 18 year age primary psychiatric diagnosis ( designate patient important source current distress ) social anxiety disorder define DSM5 criterion . A total score &gt; 60 LSAS . Physical examination laboratory finding without clinically significant abnormality . Willingness ability participate inform consent process comply requirement study protocol . A lifetime history bipolar disorder , schizophrenia , psychosis , delusional disorder obsessivecompulsive disorder ; eat disorder past 6 month ; organic brain syndrome , mental retardation cognitive dysfunction could interfere capacity engage therapy ; history substance alcohol abuse dependence ( nicotine ) last 6 month otherwise unable commit refrain alcohol use acute period study participation . PTSD within past 6 month . Entry patient mood anxiety disorder permit SAD judge predominant disorder , order increase accrual clinically relevant sample . Patients significant suicidal ideation ( MADRS item 10 score &gt; 3 ) enact suicidal behavior within 6 month prior intake exclude study participation refer appropriate clinical intervention . Patients must concurrent psychotropic medication ( e.g. , antidepressant , anxiolytic , beta blocker ) least 2 week prior initiation randomize treatment . Significant personality dysfunction likely interfere study participation . Serious medical illness instability hospitalization may likely within next year . Patients current past history seizure . Pregnant woman , lactate woman , woman childbearing potential use medically accept form contraception ( e.g. , IUD , oral contraceptive , barrier device , condom foam , implant progesterone rod stabilize least 3 month ) . Any concurrent psychotherapy initiate within 3 month baseline , ongoing psychotherapy duration direct specifically toward treatment SAD exclude . Prohibited psychotherapy include CBT psychodynamic therapy focus explore specific , dynamic cause phobic symptomatology provide management skill . General supportive therapy initiate &gt; 3 month prior acceptable . Prior nonresponse adequatelydelivered exposure ( i.e. , define patient 's report receive specific regular exposure assignment part previous treatment ) . Patients history head trauma cause loss consciousness , seizure ongoing cognitive impairment . Current use isoniazid ethionamide compound Insufficient command English language</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Social Phobia</keyword>
</DOC>